Kraig Biocraft Laboratories Inc (KBLB)

[Eskaminagaga]

If all was so great: KBLB is on spider silk, the holy grail. If this was so promising, why is there no more interest in the market?

From what I understand, there is a lot of interest in the market.

The only problem is that since KBLB is a small company financing through dilution with no income, most larger companies want to take advantage of that and wring Kim for all he is worth. From what I have seen, he refuses to bend to that kind of pressure and will not work with those companies unless they offer resonable terms which I assume happened with WM and Sigma-Aldrich. It is the same thing with Venture Capitalists who want a huge chunck of a company and a say in the day-to-day operations in exchange for financing. Government grants come with its own brand of red tape and requirements that may prevent Kim from taking KBLB in the direction that he wants and impose restrictions that could delay MS from commercialization even longer.

Is the company indeed being so vague because of competition, or do they indeed have more issues than expected

I am willing to bet that it is a little of both.

I bet larger companies are keeping an eye on every spider silk company to see what methods work vice what will not for a chance to use those ideas for themselves. The less they know about KBLB's production methods, the more likely they will not be able to use their methods and be forced to buy them out if they want to get into the market in any resonable time frame.

Also, since dilution is KBLB's sole source of funding, any percieved bad news, even if it can be overcome, could cause the stock price to fall to the point that it cannot recover. It is in Kim amd KBLB's best interest to overcome an issue and tell the stockholders that there was an issue and a solution has been found after the fact rather than tell them beforehand about the issue and that they are working on a solution. Any reduction in pps caused by that revelation would just result in additional dilution for the same amount of financing and could drive the price so low that there would be no recovery before commericalization is achieved.

I believe that after we have fully commercialized and have moved off of the dilution crutch that we are using, Kim will be much more open to sharing any issues that he is facing on the next generation fibers.